NCT02064543

Brief Summary

The project is a prospective trial comparing Zeno/GAITRite and APDM® in a cohort of persons living with parkinsonian disorders. Ambulatory patients with a parkinsonian syndrome and who are able to provide informed consent will participate in the assessments. Outcome variables include selected gait and balance parameters such as cadence, gait-cycle, stride-length, stride-velocity, turning duration, turning steps, postural sway and anticipatory postural control. These parameters will be measured by the portable inertial sensors developed by APDM® and the Zeno/GaitRite.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2013

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 22, 2014

Completed
26 days until next milestone

First Posted

Study publicly available on registry

February 17, 2014

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

September 18, 2019

Status Verified

September 1, 2019

Enrollment Period

3.5 years

First QC Date

January 22, 2014

Last Update Submit

September 16, 2019

Conditions

Keywords

Parkinson's diseasegait

Outcome Measures

Primary Outcomes (7)

  • gait parameters

    Outcome variables include selected gait and balance such as cadence

    one year

  • gait parameters

    Outcome variables include selected gait and balance such as stride-length

    one year

  • gait parameters

    Outcome variables include selected gait and balance such as stride-velocity

    one year

  • gait parameters

    Outcome variables include selected gait and balance such as turning duration

    one year

  • gait parameters

    Outcome variables include selected gait and balance such as turning steps

    one year

  • gait parameters

    Outcome variables include selected gait and balance such as postural sway

    one year

  • gait parameters

    Outcome variables include selected gait and balance such as anticipatory postural control

    one year

Study Arms (1)

ADPM and GAITRite

mobility assessments (ADPM, GAITRite) measuring gait parameters

Other: GAITRiteOther: ADPM

Interventions

mobility test assessing gait parameters

ADPM and GAITRite
ADPMOTHER

mobility test assessing gait parameters

ADPM and GAITRite

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults between the ages of 18 and 80 years of age with a primary diagnosis of PD and similar parkinsonian syndromes and clinical signs of FoG

You may qualify if:

  • Adults between the ages of 18 and 80 years of age with a primary diagnosis of PD and similar parkinsonian syndromes
  • Individuals able to walk 100 feet independently, with or without the use of an assistive device (walker, cane) and follow simple instructions.
  • Individuals with sufficient physiological systemic support to participate in the study protocol

You may not qualify if:

  • Inability to speak English secondary to the need to understand and follow multistep directions
  • A secondary diagnosis (musculoskeletal, cardiopulmonary, neurological) that excludes participation in the study
  • Inability to ambulate 100 feet independently with or without an assistive device.
  • Inability to follow simple instructions necessary for completion of the testing tasks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UT Southwestern Medical Center

Dallas, Texas, 75390, United States

Location

MeSH Terms

Conditions

Parkinsonian DisordersParkinson Disease

Condition Hierarchy (Ancestors)

Basal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Pravin Khemani, M.D.

    University of Texas Southwestern Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2014

First Posted

February 17, 2014

Study Start

July 1, 2013

Primary Completion

January 1, 2017

Study Completion

January 1, 2017

Last Updated

September 18, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations